I truly like the way this is playing out. I will admit even I thought (when I first heard 5000 samples) that it may have meant one needed 5,000 patients and I am glad I was wrong to think that!
About 500 patients and about 10 blood test samples each gives us the 5,000 as you said CP ...and more importantly....A BEAUTIFUL representation of key, multiple levels of proteins that make up MDSCs are the real puzzle pieces that can now allow an MD to have scientific proof a treatment is working: A PS Targeting treatment is working!
"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical pipeline." -- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!